| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenues | 336 | 778 | 504* | 81 |
| Cost of sales | 257 | 635 | 417* | 64 |
| Research and development | - | - | 833* | 5 |
| General and administrative | 497 | 389 | 4,710* | 1,004 |
| Total operating expenses | 754 | 1,024 | 5,960* | 1,073 |
| Operating loss | -418 | -246 | -5,456* | -992 |
| Foreign exchange gains (losses) | -18 | 39 | 115* | -14 |
| Interest income (expense) | 9 | 9 | 35* | 9 |
| Gain on deconsolidation of former subsidiary | - | - | 4,947* | - |
| Other income, net | 31 | 31 | 327* | 9 |
| Total other income, net | 22 | 79 | 5,424* | 4 |
| Loss from continuing operations before taxes | -396 | -167 | -32* | -988 |
| Income tax provision | 9 | 30 | 2* | - |
| Net loss from continuing operations | -405 | -197 | - | - |
| Net loss | -405 | -197 | -34* | -988 |
| Dividend on convertible exchangeable preferred shares | 20 | 20 | -2* | 21 |
| Deemed dividend on warrant exchange | - | - | -6,551* | -1,494 |
| Net loss applicable to common shareholders | -425 | -217 | -6,583 | -2,503 |
| Basic EPS | - | - | -2.679 | -1.31 |
| Diluted EPS | - | - | -2.679 | -1.31 |
| Basic Average Shares | 5,598,701 | 5,458,564 | 2,457,655 | 1,912,495 |
| Diluted Average Shares | 5,598,701 | 5,458,564 | 2,457,655 | 1,912,495 |
Bio Green Med Solution, Inc. (BGMS)
Bio Green Med Solution, Inc. (BGMS)